Licensing deal gives iOnctura exclusive global development rights to novel TGFβ pathway inhibitor IOA-359 Pipeline expansion builds on iOnctura’s strategy of targeting multiple cancer survival pathways with a single drug; in this case targeting therapy resistance and immune evasion pathways in addition to IOA-359’s direct effects on the tumor Grant will accelerate iOnctura’s preclinical investigation of […]
The global shortage of qualified health professionals is an increasing challenge. According to the WHO, an additional 10 million health professionals will be needed by 2030. The demand is particularly acute in low- and middle-income countries, where health systems are already under immense pressure. With the launch of the Partnership for Education of Health Professionals […]
The grant will enable leading international researchers to complete a clinical trial comparing the two most common treatment methods for preventing leg amputation among people with critical limb ischaemia. Critical limb ischaemia is a serious and debilitating disease that affects about 22 million people globally, and these are often people with diabetes and/or chronic kidney […]
Copenhagen – The Novo Nordisk Foundation and the United Nations World Food Programme (WFP) have sealed a partnership to further advance WFP’s homegrown school feeding and smallholder farmer support programmes in Rwanda and Uganda. The Novo Nordisk Foundation has committed a US$4.1 million grant to improve health, nutrition, food security and incomes for marginalized and vulnerable […]
Cambridge, UK – 26 May 2022: ENHANC3D GENOMICS (“Enhanc3D”), a biotechnology company unlocking the full potential of the human 3D genome to accelerate patient-centric medicine, announces it has been selected as one of the awardees under Johnson & Johnson Innovation’s Immunology Innovations QuickFire Challenge.
